Factors associated with timeliness of hepatitis b birth dose: a cross-sectional study in North-western Nigeria.
No Thumbnail Available
Date
2022-06-05
Authors
Ibrahim, Olayinka R
Ibraheem, Rasheedat M
Aliu, Rasaki
Lawal, Ibrahim Magaji
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
No studies focused on the hepatitis B birth dose (HepB-BD) vaccine since Nigeria adopted the strategy to reduce hepatitis B viral infection. Hence, we determined the uptake of HepB-BD, factors associated with timeliness, and those that contributed to delay.
This study was a cross-sectional descriptive study carried out at an immunization post in north-western Nigeria. We recruited 400 mother-infant pairs that presented for the first immunization and obtained relevant information, including socio-demographics and reasons for the delays. Of the 400 infants, 44 (11.0%) received HepB-BD within 24 hours (timeliness), 105 (26.3%) and 274 (68.5%) by day 7 and 14, respectively. Multivariate analysis showed that mothers' education (primary adjusted odds (AOR) 17, 95% CI 1.404, 204.611), secondary AOR 5.9, 95% CI 1.148, 29.895), and tertiary AOR 7.7, 95% CI 1.228, 48.545), and third born AOR 8.2, 1.625, 41.018) were associated with HepB-BD timeliness. Maternal-related factors were the commonest (129; 46.6%) for delayed HepB-BD, with maternal illness the most commonly cited reason (37; 28.7%). This study showed a deficient level of uptake of HepB-BD vaccines among infants. Factors that were associated with timeliness included maternal education and higher birth order. The commonest reason for delayed HepB-BD was maternal illness.
Description
Keywords
hepatitis B birth dose (HepB-BD) vaccine
Citation
Ibrahim, O. R., Ibraheem, R. M., Aliu, R., & Lawal, I. M. (2022): Factors associated with timeliness of hepatitis b birth dose: a cross-sectional study in North-western Nigeria. Folia Medica Indonesiana, 58(2), 129-136.